Cargando…
Network Pharmacology and Experimental Assessment to Explore the Pharmacological Mechanism of Qimai Feiluoping Decoction Against Pulmonary Fibrosis
Pulmonary fibrosis (PF) is one of the pathologic changes in COVID-19 patients in convalescence, and it is also a potential long-term sequela in severe COVID-19 patients. Qimai Feiluoping decoction (QM) is a traditional Chinese medicine formula recommended in the Chinese national medical program for...
Autores principales: | Yang, Yingying, Ding, Lu, Bao, Tingting, Li, Yaxin, Ma, Jing, Li, Qingwei, Gao, Zezheng, Song, Siyu, Wang, Jing, Zhao, Jiachao, Wang, Ziyuan, Zhao, Daqing, Li, Xiangyan, Wang, Zeyu, Zhao, Linhua, Tong, Xiaolin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678473/ https://www.ncbi.nlm.nih.gov/pubmed/34925028 http://dx.doi.org/10.3389/fphar.2021.770197 |
Ejemplares similares
-
Wenfei Buqi Tongluo Formula Against Bleomycin-Induced Pulmonary Fibrosis by Inhibiting TGF-β/Smad3 Pathway
por: Ding, Lu, et al.
Publicado: (2022) -
Protective Effects of the Wenfei Buqi Tongluo Formula on the Inflammation in Idiopathic Pulmonary Fibrosis through Inhibiting the TLR4/MyD88/NF-κB Pathway
por: Song, Siyu, et al.
Publicado: (2022) -
A Network Pharmacology Approach to Uncover the Mechanisms of Shen-Qi-Di-Huang Decoction against Diabetic Nephropathy
por: Di, Sha, et al.
Publicado: (2018) -
Pharmacological properties, molecular mechanisms and therapeutic potential of ginsenoside Rg3 as an antioxidant and anti-inflammatory agent
por: Wang, Jing, et al.
Publicado: (2022) -
Microbiota, co-metabolites, and network pharmacology reveal the alteration of the ginsenoside fraction on inflammatory bowel disease
por: Wang, Dandan, et al.
Publicado: (2023)